Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 143 Records) |
Query Trace: Neoplasms and FGFR1[original query] |
---|
Efficacy and potential resistance mechanisms of afatinib in advanced non-small cell lung cancer patients with EGFR G719X/L861Q/S768I. Cancer 2022 Sep . Pang Lan-Lan, Gan Jia-Di, Tan Jia-Rong, Huang Yi-Hua, Liao Jun, Liang Wei-Ting, Deng Peng-Bo, Fang Wen-Fe |
Therapeutic Targeting of FGFR Signaling in Head and Neck Cancer. Cancer journal (Sudbury, Mass.) 2022 9 28 (5): 354-362. Wang Zechen, Anderson Karen |
Shallow WGS of individual CTCs identifies actionable targets for informing treatment decisions in metastatic breast cancer. British journal of cancer 2022 Sep . Fernandez-Garcia Daniel, Nteliopoulos Georgios, Hastings Robert K, Rushton Amelia, Page Karen, Allsopp Rebecca C, Ambasager Bana, Gleason Kelly, Guttery David S, Ali Simak, Charles Coombes R, Shaw Jacqueline |
Comprehensive Genomic Profiling of Cell-Free DNA in Men With Advanced Prostate Cancer: Differences in Genomic Landscape Based on Race. The oncologist 2022 Aug . Zimmerman Raquel, Bilen Mehmet A, Heath Elisabeth I, Nandagopal Lakshminarayanan, Swami Umang, Kessel Adam, Jaeger Ellen, Wesolowski Sergiusz, Hernanadez Edgar J, Chipman Jonathan, Mack Alleda, Ravindranathan Deepak, Maughan Benjamin L, Nussenzveig Roberto, Yandell Mark, Kohli Manish, Lilly Michael B, Sartor A Oliver, Agarwal Neeraj, Barata Pedro |
Comprehensive Analysis of Genomic Alterations in Hepatoid Adenocarcinoma of the Stomach and Identification of Clinically Actionable Alterations. Cancers 2022 08 14 (16): . Zhao Rongjie, Li Hongshen, Ge Weiting, Zhu Xiuming, Zhu Liang, Wan Xiangbo, Wang Guanglan, Pan Hongming, Lu Jie, Han Weido |
Circulating Tumor DNA Identifies Diverse Landscape of Acquired Resistance to Anti-Epidermal Growth Factor Receptor Therapy in Metastatic Colorectal Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2022 8 41 (3): 485-496. Topham James T, O'Callaghan Chris J, Feilotter Harriet, Kennecke Hagen F, Lee Young S, Li Weimin, Banks Kimberly C, Quinn Katie, Renouf Daniel J, Jonker Derek J, Tu Dongsheng, Chen Eric X, Loree Jonathan |
Genomic Markers of CDK 4/6 Inhibitor Resistance in Hormone Receptor Positive Metastatic Breast Cancer. Cancers 2022 7 14 (13): . Lee Jin Sun, Yost Susan E, Li Sierra Min, Cui Yujie, Frankel Paul H, Yuan Yate-Ching, Schmolze Daniel, Egelston Colt A, Guo Weihua, Murga Mireya, Chang Helen, Bosserman Linda, Yuan Yu |
Genomic Landscape of Advanced Solid Tumors in Circulating Tumor DNA and Correlation With Tissue Sequencing: A Single Institution's Experience. JCO precision oncology 2022 6 6 e2100289. Gerratana Lorenzo, Movarek Michael, Wehbe Firas, Katam Neelima, Mahalingam Devalingam, Donahue Jeannine, Shah Ami, Chae Young K, Mulcahy Mary, Tsarwhas Dean, Villaflor Victoria, Kalyan Aparna, Hussein Maha, Patel Jyoti, Chandra Sunandana, Platanias Leonidas C, Gradishar William, Cristofanilli Massimo, Behdad Am |
Genetic determinants of lung cancer: Understanding the oncogenic potential of somatic missense mutations. Genomics 2022 6 114 (4): 110401. Dhakar Ramgopal, Dakal Tikam Chand, Sharma Am |
mTOR pathway gene mutations predict response to immune checkpoint inhibitors in multiple cancers. Journal of translational medicine 2022 6 20 (1): 247. Cheng Lei, Wang Yanan, Qiu Lixin, Chang Yuanyuan, Lu Haijiao, Liu Chenchen, Zhang Bo, Zhou Yan, Bai Hao, Xiong Liwen, Zhong Hua, Nie Wei, Han Baoh |
Genomic Alteration Spectrum of Non-Small Cell Lung Cancer Patients in East-China Characterized by Tumor Tissue DNA and Cell-Free DNA. OncoTargets and therapy 2022 5 15 571-584. Li Jie, Chen Siwen, Xue Hui, Wang Haoyi, Huang Tianwei, Xie Hongya, He Jiang, Ke Cai, Yu Zhaonan, Ni B |
Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer. Frontiers in oncology 2022 12 778511. Hao Chunfang, Wang Chen, Lu Ning, Zhao Weipeng, Li Shufen, Zhang Li, Meng Wenjing, Wang Shuling, Tong Zhongsheng, Zeng Yanwu, Lu Leil |
Molecular landscape and therapeutic alterations in Asian soft-tissue sarcoma patients. Cancer medicine 2022 May . Gan Meifu, Zhang Chen, Qiu Liqing, Wang Yue, Bao Hua, Yu Ruoying, Liu Rui, Wu Xue, Shao Yang, Hou Peifeng, Fei Zhengl |
Identification of mutation patterns and circulating tumour DNA-derived prognostic markers in advanced breast cancer patients. Journal of translational medicine 2022 05 20 (1): 211. Liao Hao, Zhang Jiayang, Zheng Tiantian, Liu Xiaoran, Zhong Jianxin, Shao Bin, Dong Xiaoxi, Wang Xiaohong, Du Pan, King Bonnie L, Jia Shidong, Yu Jianjun, Li Huipi |
The role of next-generation sequencing in the examination of signaling genes in Brca1/2-negative breast cancer cases. Annals of human genetics 2022 Dec . Cine Naci, Ugurtas Cansu, Gokbayrak Merve, Aydin Duygu, Demir Gulhan, Kuru Seda, Sunnetci-Akkoyunlu Deniz, Eren-Keskin Seda, Simsek Turgay, Cabuk Devrim, Aksu Maksut Gorkem, Canturk Nuh Zafer, Savli Hak |
Pan-tumor landscape of fibroblast growth factor receptor 1-4 genomic alterations. ESMO open 2022 12 7 (6): 100641. Murugesan K, Necchi A, Burn T C, Gjoerup O, Greenstein R, Krook M, López J A, Montesion M, Nimeiri H, Parikh A R, Roychowdhury S, Schwemmers S, Silverman I M, Vogel |
Profiling the somatic mutational landscape of breast tumors from Hispanic/Latina women reveals conserved and unique characteristics. Cancer research 2023 5 . Yuan Chun Ding, Hanbing Song, Aaron W Adamson, Daniel Schmolze, Donglei Hu, Scott Huntsman, Linda Steele, Carmina S Patrick, Shu Tao, Natalie Hernandez, Charleen D Adams, Laura Fejerman, Kevin Gardner, Anna María Nápoles, Eliseo J Perez-Stable, Jeffrey N Weitzel, Henrik Bengtsson, Franklin W Huang, Susan L Neuhausen, Elad Z |
ER+, HER2- advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes. Molecular oncology 2023 3 . Chen Jessica W, Jacot William, Cortés Javier, Krop Ian E, Dent Susan, Harbeck Nadia, De Laurentiis Michelino, Diéras Véronique, Im Young-Hyuck, Stout Thomas J, Schimmoller Frauke, Savage Heidi M, Hutchinson Katherine E, Wilson Timothy |
Prevalent landscape of tumor genomic alterations of luminal B1 breast cancers using a comprehensive genomic profiling assay in Taiwan. Breast cancer (Tokyo, Japan) 2023 12 . Bo-Fang Chen, Yi-Fang Tsai, Pei-Ju Lien, Yen-Shu Lin, Chin-Jung Feng, Yen-Jen Chen, Han-Fang Cheng, Chun-Yu Liu, Ta-Chung Chao, Jiun-I Lai, Ling-Ming Tseng, Chi-Cheng Hua |
Clinicopathologic and genetic analysis of invasive breast carcinomas in women with germline CHEK2 variants. Breast cancer research and treatment 2023 12 . Christopher J Schwartz, Nikka Khorsandi, Amie Blanco, Rita A Mukhtar, Yunn-Yi Chen, Gregor Krin |
The ctDNA-based postoperative molecular residual disease status in different subtypes of early-stage breast cancer. Gland surgery 2023 1 11 (12): 1924-1935. Yang Yang, Zhang Jie, Li Jiao-Yang, Xu Lu, Wang Si-Ning, Zhang Jun-Qi, Xun Zhou, Xia Yu, Cao Jian-Bo, Liu Yang, Shi Li-Yan, Li Wei, Shi Yong-Lei, He Yuan-Ge, Gu De-Jian, Yu Zheng-Yuan, Chen Kai, Lan Ji |
Lung cancer presenting with central nervous system metastasis: Clinicopathological and molecular analysis of 171 cases. Annals of diagnostic pathology 2023 1 63 152082. Demleitner Madeleine, Erlenbach-Wünsch Katharina, Coras Roland, Erber Ramona, Polifka Iris, Eyüpo?lu Ilker, Fuchs Florian, Hartmann Arndt, Agaimy Abb |
A pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. Journal of thoracic disease 2024 7 16 (6): 3782-3793. Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler, Jeffrey P Ward, Siddhartha Devarakonda, Timothy P Rearden, Ramaswamy Govindan, Saiama N Waq |
Significance of Multi-Cancer Genome Profiling Testing for Breast Cancer: A Retrospective Analysis of 3326 Cases from Japan's National Database. Genes 2024 6 15 (6): . Kyoka Kawabata, Hinano Nishikubo, Saki Kanei, Rika Aoyama, Yuki Tsukada, Tomoya Sano, Daiki Imanishi, Takashi Sakuma, Koji Maruo, Yurie Yamamoto, Qiang Wang, Zhonglin Zhu, Canfeng Fan, Masakazu Yashi |
Comprehensive genomic profiling and therapeutic implications for Taiwanese patients with treatment-naïve breast cancer. Cancer medicine 2024 6 13 (12): e7384. Shang-Hung Chen, Ka-Po Tse, Yen-Jung Lu, Shu-Jen Chen, Yu-Feng Tian, Kien Thiam Tan, Chien-Feng |
Somatic KMT2D loss-of-function mutations in lung squamous cell carcinoma: a single-center cohort study. Journal of thoracic disease 2024 6 16 (5): 3338-3349. Zekui Fang, Xiping Wu, Li Xiao, Chunli Wang, Yanyan Zhao, Qingchao Zhang, Paola Anna Jablonska, Alonso La Rosa, Wolfram C M Dempke, Muhammad Furqan, Huizhen F |
Comprehensive genomic profiling from C-CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1. Clinical endocrinology 2024 6 . Yuki Saito, Hidenori Kage, Kenya Kobayashi, Teru Kamogashira, Osamu Fukuoka, Koji Yamamura, Satoshi Yamashita, Masahiko Tanabe, Katsutoshi Oda, Kenji Kon |
Evaluation of molecular residual disease in operable non-small cell lung cancer with gene fusions, MET exon skipping or de novo MET amplification. Frontiers of medicine 2024 5 . Rui Fu, Yuanyuan Xiong, Miao Cai, Fang Li, Rongrong Chen, Yilong Wu, Wenzhao Zho |
Clinicogenomic characterization of inflammatory breast cancer. bioRxiv : the preprint server for biology 2024 5 . Nolan Priedigkeit, Beth Harrison, Robert Shue, Melissa Hughes, Yvonne Li, Gregory J Kirkner, Liam F Spurr, Marie Claire Remolano, Sarah Strauss, Janet Files, Anne-Marie Feeney, Libby Grant, Ayesha Mohammed-Abreu, Ana Garrido-Castro, Romualdo Barroso Sousa, Brittany Bychkovsky, Faina Nakhlis, Jennifer R Bellon, Tari A King, Eric P Winer, Neal Lindeman, Bruce E Johnson, Lynette Sholl, Deborah Dillon, Beth Overmoyer, Sara M Tolaney, Andrew Cherniack, Nancy U Lin, Filipa Lyn |
Phase II Study of Erdafitinib in Patients With Tumors With FGFR Amplifications: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol K1. JCO precision oncology 2024 4 8 e2300406. Jun Gong, Alain C Mita, Zihan Wei, Heather H Cheng, Edith P Mitchell, John J Wright, S Percy Ivy, Victoria Wang, Robert C Gray, Lisa M McShane, Larry V Rubinstein, David R Patton, P Mickey Williams, Stanley R Hamilton, Ajjai S Alva, James V Tricoli, Barbara A Conley, Carlos L Arteaga, Lyndsay N Harris, Peter J O'Dwyer, Alice P Chen, Keith T Flaher |
- Page last reviewed:Feb 1, 2024
- Content source: